CARLSBAD, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announced today that CEO…
Qualigen to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Share this article
More News





Stock Market News and Research Tools
August 31, 2026

Vietnam to Launch Pilot Crypto Asset Market
August 31, 2026
